Clinical Trial

Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer

Study acronym: PANC-O-MICS
Recruiting
View on ClinicalTrials.gov →
Summary
Specifically, in this project, the objective will be developped a model to capture imaging-based tumor heterogeneity with multiscale radiomics approach by obtaining the mirror tumor image at in vivo MRI, ex vivo MRI at histology. This imaging model giving a perfect virtual histology tumor representation will be secondary implemented on routine in vivo clinical MRI for early cancer detection and treatment monitoring. Successful completion of this proposal will lead to a comprehensive non invasive characterisation of pancreatic cancer and will be a game changer in patient management.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-11-17; most recent amendment 2025-02-11.
Status change: Not Yet Recruiting → Recruiting 2023-12-27
Trial Details
NCT Number NCT06144762
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions Pancreas Cancer
Enrollment 150 participants
Start Date 2023-12-19
Primary Completion 2029-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2025-02-12